PharmaResearch Co (XKRX:214450) 3-Year EBITDA Growth Rate : 29.50% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co 3-Year EBITDA Growth Rate?

PharmaResearch Co's EBITDA per Share for the three months ended in Dec. 2023 was ₩2,349.62.

During the past 12 months, PharmaResearch Co's average EBITDA Per Share Growth Rate was 65.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 29.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 37.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of PharmaResearch Co was 46.30% per year. The lowest was -1.00% per year. And the median was 29.50% per year.

Competitive Comparison of PharmaResearch Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, PharmaResearch Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaResearch Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaResearch Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PharmaResearch Co's 3-Year EBITDA Growth Rate falls into.

PharmaResearch Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PharmaResearch Co (XKRX:214450) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

PharmaResearch Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaResearch Co (XKRX:214450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400

Website

http://www.pr-products.co.kr

PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines